Skip to main content

Table 2 Trial adherence and use of lipid-modifying medication post-trial

From: Legacy effect of fibrate add-on therapy in diabetic patients with dyslipidemia: a secondary analysis of the ACCORDION study

TimeTreatmentProportion on-treatment (%)
Fenofibrate groupPlacebo group
Year 1Fenofibrate/placebo91.491.2
Simvastatin94.595.5
Year 2Fenofibrate/placebo88.891.5
Simvastatin93.696.1
Year 3Fenofibrate/placebo87.290.2
Simvastatin91.392.9
Year 4Fenofibrate/placebo85.386.3
Simvastatin92.992.5
Trial exit visitFenofibrate/placebo82.786.3
Simvastatin93.191.0
1st post-trial visitFibrate7.27.4
Stains77.178.4
Last post-trial visitFibrate5.44.8
Stains72.074.0